Long-term results of myocardial revascularization.

During 1970 to 1977, among 1,733 patients who underwent isolated coronary bypass grafting, the operative mortality was 2.5 percent. Actuarial 5 year survival is 88.1 percent. At an average follow-up of 46 months (range 13 to 108), 90 percent of patients remain angina-free or with symptomatic improvement. The 5 year survival rate of patients with single vessel coronary artery disease is 97.9 percent. In patients with multivessel disease, operative survival appears to be favorably influenced by the presence of normal preoperative ventricular function. Late survival is significantly better in patients with multivessel disease with normal preoperative ventricular function or with complete revascularization. Risk of perioperative myocardial infarction has been appreciably reduced by the introduction of cold potassium chloride cardioplegia. Late myocardial infarction has occurred at an average annual risk of 1.46 percent. These data show that long-term survival and a small incidence of late myocardial infarction after myocardial revascularization are more likely in patients who undergo complete revascularization before significant left ventricular myocardial damage has occurred.

Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS).

The 3 year cumulative survival rate of 1,492 patients with left main coronary artery disease (50 percent or greater stenosis of luminal diameter) enrolled in the Collaborative Study in Coronary Artery Surgery (CASS) was 91 percent for the surgical group and 69 percent for patients treated medically (p less than 0.0001). Mortality was significantly greater in patients with impaired left ventricular function. The difference between medical and surgical therapy was significant for patients who had normal, moderately abnormal and severely impaired left ventricular function and for patients with stenosis of the left main coronary artery of 50 to 59, 60 to 69, 70 to 79 and 80 percent or greater. Aortocoronary bypass surgery did not significantly improve survival in patient subgroups who had (1) a nonstenotic dominant right or balanced coronary circulation, (2) a stenotic dominant right coronary artery and normal left ventricular function, and (3) left main coronary stenosis of 50 to 59 percent and normal or mildly abnormal left ventricular function. The Cox proportional hazards model was used to select baseline variables that were independent predictors of long-time mortality. The model selected left ventricular score, age, congestive heart failure score, hypertension, percent left main coronary arterial stenosis and coronary arterial dominance as the baseline variables most predictive of long-term survival. A clinical and angiographic prognostic risk index developed from these six baseline variables showed significantly improved survival for the surgical cohort in each of four risk categories. In the best and worst risk category, the 3 year survival rate was 97 and 82 percent, respectively, for the surgical group and 85 and 34 percent, respectively, for the medical group (p less than or equal to 0.0002). The data from this observational study show that coronary bypass surgery prolongs life in most patients with left main coronary artery disease, particularly those who have severe narrowing of the left main coronary artery or impaired left ventricular function. The results permit a better understanding of the natural history of left main coronary artery disease and permit a more accurate estimate of long-term survival for individual patients through the use of a clinical-angiographic risk index.

The role of the 'pericardial window' in AIDS.

BACKGROUND: The leading cause of pericardial effusion in urban hospitals is now AIDS-related pathologies. Clinically, these effusions are a diagnostic and management dilemma. In our institution, pericardial biopsy and operative drainage have become part of the diagnostic and management plan. Surgical intervention, however, has appeared to have little clinical impact. METHODS: A retrospective review was conducted of all patients (n = 29) diagnosed as having AIDS who underwent "pericardial window" for pericardial effusions from 1986 to 1994. RESULTS: Fluid cultures and pericardial biopsy were performed in all cases. Twenty-four percent of culture or biopsy specimens were diagnostic (7 of 29 = 2 adenocarcinoma, 3 lymphoma, 1 Staphylococcus aureus, 1 Mycobacterium tuberculosis). In 94% of cases, there was no change in clinical management based on operative results. In 4 of 7 cases, the patients were ineligible for the indicated therapy based on underlying illness and in 1 of 7, the patient was receiving appropriate therapy for previously diagnosed disease. Ventilatory complications were noted in 17%. Three patients did not wean from the ventilator and died shortly after the operation. Sixty-nine percent mortality was noted at 8 weeks post-operatively. One hundred percent mortality was noted at 22 weeks with 86% follow-up. CONCLUSION: AIDS-related pericardial effusion is associated with a grave prognosis. Operations for diagnostic benefit provide little practical information and are not justified.

Hemothorax associated with endometriosis.

Fifteen cases have been reported of pleural effusion associated with endometriosis. Common characteristics that may aid in the diagnosis are discussed and an additional case is presented.

Atypical mycobacteria and the xenograft valve.

During a 4 month interval, cultures taken at the time of porcine xenograft valve implantation grew a fastidious atypical mycobacterium, Mycobacterium chelonei (Runyon's groups IV), in eight of 20 patients. Initial growth occurred at 2 to 3 weeks in thioglycollate broth only; detailed biochemical and bacteriologic evaluation demonstrates altered catalase activity accounting for its initial slow growth. Only one patient has manifested clinical evidence of infection 5 months after mitral valve replacement. A large pericardial effusion required pericardiectomy. Pericardial tissue and fluid have grown M. chelonei with the same growth characteristics as the initial valve culture. It is recommended that manufacturers of xenograft valve bioprostheses maintain a quarantine of 6 weeks until cultures, smears of culture broth, and microscopic evaluation of aortic wall coupons are negative. Users of these prostheses should keep cultures for a minimum of 3 weeks. Should positive cultures result, antimicrobial therapy should be considered only with clinical evidence of infection.

The rationale for operative therapy of symptomatic single-vessel coronary artery disease.

During an 8 year interval, 184 patients with symptomatic single-vessel disease underwent coronary artery bypass grafting (CABG). There were no operative deaths and only one late cardiac death (5 year cumulative survival 97.9%). At 48 months mean follow-up, 91% are angina free or improved. The low incidence of perioperative and late myocardial infarction (MI) and the preservation of ventricular function seen on follow-up catheterization suggest that coronary bypass operations yield significant benefits in severely symptomatic patients with single-vessel disease. Evidence is presented which supports the idea that single-vessel coronary artery disease may be a unique manifestation of coronary atherosclerosis and not one stage in a continuum.

Bypass grafts to the left anterior descending coronary artery: saphenous vein versus internal mammary artery.

During the interval 1972 to 1977, of 1,522 patients undergoing isolated coronary artery bypass grafting (CABG), 1,459 received grafts to the left anterior descending coronary artery (LAD). Internal mammary artery (IMA) was used in 765 patients and reversed saphenous vein graft (SVG) in 694 patients. Choice of bypass graft was nonrandom. Clinical follow-up is available in 98% of patients. Angiography has been obtained in 69% of eligible patients at 1 month, 65% at 1 year, 62% at 3 years, and 63% at 5 years. There was no difference in operative mortality rates (IMA 1.4%, SVG 1.9%) or 5 year actuarial survival rates (IMA 87.6%, SVG 88.7%). Graft flows were consistently higher at operation with the SVG, but patency rates at each interval were significantly higher with the IMA. Perioperative and late myocardial infarction occurred significantly less often in IMA patients. Superiority in IMA graft patency became apparent after an initial "learning curve" of 2 years of experience. Maintenance and/or restoration of normal left ventricular function was more common in IMA patients operated upon after the initial 2 year experience. IMA grafts are recommended for LAD bypass when the LAD is 2.0 mm in diameter or less. Early results with sequential SVG to the LAD suggest that this may be a realistic alternative to the IMA and may approach the 1 year IMA graft patency rate of 92.6%.

Supraventricular tachyarrhythmias after myocardial revascularization: a randomized trial of prophylactic digitalization.

The success of prophylactic digitalization in reducing the incidence of supraventricular tachyarrhythmias (SVT) was studied in 140 randomly grouped, consecutive patients undergoing myocardial revascularization operations. The test group received either 1 or 1.5 mg. of digoxin the day before operation and were maintained postoperatively on 0.25 mg. of digoxin daily. There was a significant increase (p less than 0.05) in the incidence of SVT in the treated patients (17 of 61 or 27.8 percent) vs. the untreated patients (nine of 79 or 11.4 percent). There was no significant difference in SVT with the two digitalization dosage levels (31.6 percent with 1 mg. vs. 21.7 percent with 1.5 mg.). Prophylactic digitalization demonstrates no benefit in the prevention of SVT following myocardial revascularization and may, in fact, predispose the patient to these arrhythmias.

Coronary-subclavian steal.

Of 450 patients undergoing internal mammary artery grafts for coronary artery bypass, proximal subclavian artery stenosis with reversal of flow in the internal mammary and vertebral arteries ("coronary-subclavian steal") subsequently developed in two patients. Carotid-subclavian bypass successfully reestablished antegrade blood flow in the ipsilateral internal mammary and vertebral arteries in both patients. Arch aortography is indicated preoperatively in myocardial revascularization patients in the presence of cerebrovascular symptoms, upper extremity blood pressure gradients, and carotid or subclavian bruits. Should subclavian artery stenosis develop subsequent to myocardial revascularization, carotid-subclavian or acillary-axillary bypass can effectively restore antegrade blood flow and reverse the coronary-subclavian steal.

Nonsyphilitic coronary ostial stenosis.

From October 1970 to June 1977, a total of 15 patients (12 women) were seen with atherosclerotic coronary ostial stenosis (14 left, one right). All patients had angina and two had aortic valve disease. Additional coronary arterial disease was present in nine. One patient declined surgery and died four months later after myocardial infarction. All patients had coronary bypass grafts and two had aortic valve replacement. One patient with valve replacement and one with preoperative cardiogenic shock died postoperatively. Angina recurred nine months postoperatively in one patient; the others (11) are free of angina. Postoperative catheterization from two weeks to 4.5 years in ten of 12 showed 11 of 13 vein grafts and eight of nine internal mammary artery grafts to be patent. In three patients, only a single left-sided coronary bypass was placed to the left anterior descending artery, because the circumflex branches were too small. Ideally, two left-sided bypass grafts should be placed for left ostial disease.

Paraplegia following intraaortic balloon assistance.

In a patient receiving intraaortic balloon counterpulsation following myocardial revascularization, paraplegia developed two days post-operatively. Postmortem examination demonstrated a dissecting hematoma of the thoracic aorta and spinal cord infarction. The neurological deficit is thought to be due to embarrassment of spinal cord blood supply, and mechanisms of injury are discussed.

Use of the variable-length intraluminal sutureless graft.

From August 1987 to May 1988 we treated 4 patients with acute ascending aortic dissections with a variable-length intraluminal aortic prosthesis. This operation uses profound hypothermic circulatory arrest and represents a refinement of existing techniques. There was no mortality, and morbidity was minimal. Modifications of this technique can be used in performing proximal aortic root reconstruction with a composite valved conduit. The use of a variable-length intraluminal prosthesis and hypothermic circulatory arrest is illustrated. This is a safe and useful technique in select cases of acute ascending aortic dissection.

Surgical approach for renal cell carcinoma metastatic to the left atrium.

Metastatic tumor involvement of the left atrium via the pulmonary veins has been reported rarely. We report a 58-year-old patient with renal cell carcinoma metastatic to the left atrium via the pulmonary veins and the lower lobe of the left lung. An unusual surgical approach combining median sternotomy and videoscope-assisted thoracic surgery was used in resecting the atrial mass and performing a lower lobe resection.

Reduction of myocardial injury with verapamil before aortic cross-clamping.

The effect of verapamil administered before aortic cross-clamping was assessed in 40 patients undergoing elective coronary artery bypass grafting. Myocardial protection consisted of cold blood potassium cardioplegia, topical ice slush, and moderate (28 degrees C) systemic hypothermia. Patients were randomly divided into two groups: group 1 (18 patients) received verapamil (0.1 mg/kg up to 10 mg) intravenously three to five minutes before aortic cross-clamping; group 2 (22 patients) did not (control). Myocardial injury was assessed by cumulative release of the cardiac-specific isoenzyme of creatine kinase (CK-MB) after release of the aortic cross-clamp. Release of CK-MB was significantly lower in the verapamil group (44.9 +/- 6.2 versus 72.2 +/- 9.0 IU at 24.5 hours, p = 0.005). Calculated total infarct size was also lower in the verapamil group (6.0 +/- 0.9 versus 8.9 +/- 1.0 g-Eq, p = 0.035). Individual CK-MB release curves showed either one or two peaks. The two-peak pattern was more frequent in control patients (18 of 21 control patients versus 6 of 18 verapamil patients, p = 0.001) and was associated with a larger infarct size. Atrioventricular pacing was not required in any verapamil patient, but was needed in 1 control patient. We conclude that verapamil administered before aortic cross-clamping protects against myocardial injury during coronary artery bypass grafting with no increase in the incidence of atrioventricular block.

The risks and benefits of thrombolytic therapy in acute aortic and mitral prosthetic valve dysfunction: report of a case and review of the literature.

A patient with acute thrombosis of a St. Jude mitral prosthesis was treated with streptokinase with initial success. Subsequent recurrent thrombosis and embolism prompted operative revision. Because the use of thrombolytic agents in this setting is somewhat controversial, we searched the literature for all reports of aortic or mitral prosthetic valve dysfunction treated this way. The cases of 58 patients treated 62 times were reviewed for efficacy of therapy and morbidity. Thrombolytic therapy may be useful in patients with prosthetic valve thrombosis causing critical hemodynamic compromise. It is frequently the only treatment needed. Further, it may help reduce operative risk for those patients in whom complete resolution is not possible. The incidence of systemic embolism is 18%, however, neurological events are usually limited and transient.

Serial changes in renal function in cardiac surgical patients.

Cardiopulmonary bypass is widely believed to be injurious to renal function. The low incidence of renal dysfunction with modern techniques of bypass led us to reexamine this concept by monitoring urine output and creatinine clearance in 18 adult patients undergoing nonpulsatile, hemodilution cardiopulmonary bypass for coronary artery bypass grafting (12 patients) or valve procedures (6 patients). Samples were taken before, during (mean duration of bypass, 105 +/- 26 minutes [+/- standard deviation]), and every two hours after bypass for 24 hours. Urine output (42 +/- 37.7 mL/h) and creatinine clearance (57 +/- 40.4 mL/min) were surprisingly low in the period before cardiopulmonary bypass (all values normalized to a body surface area of 1.73 m2). Urine volumes rose to 305 +/- 149.6 mL/h and creatinine clearance to 252 +/- 176.9 mL/min during bypass and decreased to stable values after eight hours in the postoperative unit (urine output, approximately 60 mL/h, and creatinine clearance, approximately 75 mL/min). Renal dysfunction did not develop in any patient. Nine patients who required loop diuretics for low urine output 18 hours postoperatively had a sustained increase in both urine output and creatinine clearance lasting up to six hours. We conclude the following: modern techniques of cardiopulmonary bypass are not injurious to renal function; urine output and creatinine clearance are decreased before cardiopulmonary bypass, probably because of preoperative dehydration; and loop diuretics in the postoperative period increase both urine output and creatinine clearance for as long as six hours after administration.

Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant.

Myo-inositol hexaphosphate (phytic acid), a highly charged antioxidant, has been found to chelate metal ions such as iron and calcium and to scavenge hydroxyl radicals, .OH. This study examined the efficacy of this antioxidant and redox agent in attenuating myocardial reperfusion injury. Sprague-Dawley rats were injected intravenously with three different doses of phytic acid (group 1, saline solution only, control; group 2, 1.5 mg/100 g; group 3, 7.5 mg/100 g; group 4, 15 mg/100 g) 30 minutes before excision of hearts. Isolated hearts were prepared by the Langendorff technique. Global ischemia was induced for 30 minutes, followed by 30 minutes of reperfusion. As expected, in group 1, reperfusion was associated with enhanced creatine kinase release, reduced coronary flow, poor recovery of ventricular function as evidenced by reduced left ventricular developed pressure and the first derivative of left ventricular pressure, and increased lipid peroxidation. Groups 3 and 4, but not group 2, demonstrated myocardial protection as evidenced by reduced creatine kinase release, improved left ventricular function and coronary flow, and decreased lipid peroxidation compared with the control group. These results suggest that potential use of this antioxidant in salvaging the heart from ischemic and reperfusion injury.

Late patency of the internal mammary artery as a coronary bypass conduit.

From January, 1972, through August, 1977, 472 patients had internal mammary artery (IMA) coronary bypass, of which 100 were double-IMA bypasses. We selected those patients having a widely patent IMA one year postoperatively who then had a second catheterization 49 to 105 (mean, 64) months following operation. None of the 93 patients who met these criteria was specifically recalled for this study; they all had follow-up catheterizations for multiple other reasons. All of the 91 left IMA and 22 right IMA bypasses (total, 113) were patent at late catheterization, but 1 right IMA was diffusely narrowed. One left IMA had acute angulation with 50% stenosis proximal to the distal anastomosis, which was unchanged over the follow-up interval. There were 100 patent saphenous vein bypasses at one year and 87 at late catheterization. Late closure of coronary bypass grafts is secondary to progression of coronary disease, atherosclerosis of the bypass conduit, or intimal proliferation. Because we have not encountered the latter two causes of conduit closure, IMA grafts remain our graft of choice for nonemergent operations in patients under 60 years of age having revascularization of the left anterior descending coronary artery system.

Late sequelae of perioperative myocardial infarction.

The late suquelae of myocardial injury occurring at the time of direct myocardial revascularization are unknown. Fifty of 500 consecutive patients undergoing aortocoronary bypass grafting developed both electrocardiographic and enzymatic evidence of myocardial injury. They were matched with 50 patients of similar age, sex, history of previous infarction, severity of angina, degree of coronary arteriosclerosis, and level of ventricular function as determined by preoperative angiographic studies. The conduct of the operation was identical in each group except for prolongation of total cross-clamp time in those patients with myocardial injury. The total number of vessels grafted, the conduit used, and the operative mean graft flow were similar. Results of treadmill stress testing at 24 to 36 months were not significantly different between groups. Angina status, long-term survival, graft patency, and ventricular function were not adversely affected by intraoperative myocardial injury. However, postoperative ventricular function and stress test performance were related to graft patency.

Clinical experience with cold blood as the vehicle for hypothermic potassium cardioplegia.

Intermittent cold ischemic arrest was compared with hypothermic potassium cardioplegia using cold blood as the vehicle in two consecutive series of patients having isolated coronary bypass grafting. Between January 1, 1977, and June 30, 1977, 196 patients were operated on using cold ischemic arrest. The incidence of perioperative infarction was 14.3%, and mean total myocardial ischemia time was 42 +/- 1.2 minutes. From July 1, 1977, to June 30, 1978, there were 428 operations done using cold blood with potassium. The incidence of perioperative infarction was 5.6% (p less than 0.005), and the mean total myocardial ischemic time was 80 +/- 2.1 minutes. In the five years prior to this study, the incidence of perioperative infarction was constant at 13% while operative mortality was declining from 5 to 1% and the need for postoperative myocardial support was declining also. Use of cold blood potassium cardioplegia compared with cold ischemic arrest for myocardial protection during coronary artery operations has significantly reduced the incidence of perioperative infarction while doubling cross-clamp time.